Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
- 1 July 2005
- Vol. 339 (2) , 164-175
- https://doi.org/10.1016/j.virol.2005.06.002
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+T-Cell Peptide Epitope of Vaccinia and Variola VirusesJournal of Virology, 2004
- Development of a Novel Vaccinia‐Neutralization Assay Based on Reporter‐Gene ExpressionThe Journal of Infectious Diseases, 2003
- Prime‐Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Virus–2 Glycoprotein D Elicits Greater Specific Antibody and Cytokine Responses than DNA Vaccine AloneThe Journal of Infectious Diseases, 2002
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus ChallengeThe Journal of Infectious Diseases, 2000
- Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory routeJournal of General Virology, 1990
- Photochemical Inactivation of DNA and RNA Viruses by Psoralen DerivativesJournal of General Virology, 1978
- MVA-Stufenimpfung gegen PockenDeutsche Medizinische Wochenschrift (1946), 1974
- Inactivated Smallpox Vaccine: Immunogenicity of Inactivated Intracellular and Extracellular Vaccinia VirusJournal of General Virology, 1971
- Respiratory Infection of Mice with Vaccinia VirusJournal of General Virology, 1967